BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6494200)

  • 1. Effects of nicardipine, nifedipine, verapamil, and diltiazem on urine volume, sodium and potassium excretion and plasma aldosterone levels in the rat.
    Rosenkranz RP; McClelland DL; Roszkowski AP
    Proc West Pharmacol Soc; 1984; 27():67-72. PubMed ID: 6494200
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of calcium-entry blockers on the diuretic response to hydrochlorothiazide in the rat.
    Rao VS; Menezes AM; Gadelha MG; Fonteles MC
    Braz J Med Biol Res; 1988; 21(5):1023-5. PubMed ID: 3248231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium entry blockers: antihypertensive and natriuretic effects in experimental animals.
    Nagao T; Yamaguchi I; Narita H; Nakajima H
    Am J Cardiol; 1985 Dec; 56(16):56H-61H. PubMed ID: 3878075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nifedipine, verapamil and diltiazem on renal function.
    Chellingsworth MC; Kendall MJ
    Br J Clin Pharmacol; 1988 May; 25(5):599-602. PubMed ID: 3044425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of nicardipine on blood pressure, renal function and plasma aldosterone in normotensive volunteers.
    van Schaik BA; Hene RJ; Geyskes GG
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):88S-94S. PubMed ID: 3896284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of calcium channel blockers on potassium homeostasis.
    Freed MI; Rastegar A; Bia MJ
    Yale J Biol Med; 1991; 64(2):177-86. PubMed ID: 1750228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric modulation by diltiazem and verapamil of [3H]nitrendipine binding to calcium channel sites in rat brain.
    Schoemaker H; Boles RG; Roeske WR; Yamamura HI
    Proc West Pharmacol Soc; 1983; 26():219-24. PubMed ID: 6310626
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of nicardipine and other Ca2+-antagonists on catecholamine transport into chromaffin granule membrane vesicles.
    Tachikawa E; Takahashi S; Shimizu C; Ohtsubo N; Kashimoto T; Takahashi E
    Res Commun Chem Pathol Pharmacol; 1984 Aug; 45(2):305-8. PubMed ID: 6484315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of the natriuretic hormone in the action of nifedipine and verapamil on the kidneys].
    Filipets ND
    Eksp Klin Farmakol; 1997; 60(1):40-1. PubMed ID: 9162282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.
    Hamm CW; Opie LH
    Circ Res; 1983 Feb; 52(2 Pt 2):I129-38. PubMed ID: 6831647
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.
    Winquist RJ; Siegl PK; Baskin EP; Bohn DL; Morgan G; Wallace AA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):103-9. PubMed ID: 6747822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of calcium entry blockers on renin-angiotensin-aldosterone system, renal function and hemodynamics, salt and water excretion and body fluid composition.
    Bauer JH; Sunderrajan S; Reams G
    Am J Cardiol; 1985 Dec; 56(16):62H-67H. PubMed ID: 2933950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calcium antagonists in congestive heart failure].
    Barbieri L; Mestroni L; Camerini F
    G Ital Cardiol; 1988 Nov; 18(11):989-96. PubMed ID: 3073994
    [No Abstract]   [Full Text] [Related]  

  • 16. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
    Boles RG; Yamamura HI; Schoemaker H; Roeske WR
    J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation of Ca2+ efflux from the heart to the concentration of Ca-channel blockers].
    Khmel'-Dunaĭ GN; Narushiavichus EV
    Biull Eksp Biol Med; 1985 Nov; 100(11):559-61. PubMed ID: 4063502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of calcium-channel blockers on cell proliferation, DNA and collagen syntheses, and EGF receptors of cultured gingival fibroblasts derived from human nifedipine, nicardipine and nisoldipine responders.
    Matsumoto H; Noji I; Akimoto Y; Fujii A
    J Oral Sci; 2001 Dec; 43(4):261-8. PubMed ID: 11848193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal differences in actions of calcium channel blockers on K+ accumulation, cardiac function, and high-energy phosphate levels in ischemic guinea pig hearts.
    Sato R; Yamazaki J; Nagao T
    J Pharmacol Exp Ther; 1999 May; 289(2):831-9. PubMed ID: 10215660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.